Reference no: EM131704692

Question - During 2017 the Lung Association received a contribution of marketable securities that were to be placed in a permanent endowment fund. Neither donor stipulations nor applicable state law requires that capital gains or increases in value be added to the endowment principal. The income from the securities was to be restricted to research in pulmonary diseases. The following schedule indicates the value of the securities as of the date of receipt (labeled "cost"), the fair value at December 31, 2017, and the unrealized gains and losses of the year.

Endowment Portfolio as of December 31, 2017 (in thousands)

Cost Fair Value Unrealized Gain (Loss)

Northwest Industries $260 $275 $15

Campbell Corp. 317 304 (13)

St. Regis, Inc. 141 171 30

$718 $750 $32

1. Prepare a journal entry to record the unrealized net gain during the year. Be sure to indicate the type of fund+(unrestricted, temporarily restricted, or permanently restricted) in which the entry would be made. Assuming no other transactions and no other assets in the relevant funds, show how the investments would be reported on the hospital's year-end 2017 statement of financial position.

2. During 2018, the hospital sold Northwest Industries for $280. Prepare appropriate journal entries to record the sale. Credit the gain to the same account in which you credited the unrealized appreciation of 2017.

3. As of December 31, 2018, the market value of Campbell Corp. had increased to $320; that of St. Regis, Inc., to $180. Prepare a journal entry to record the unrealized gain during the year. Show how the association would report the investment portfolio on its December 31, 2018, statement of financial position. You may combine the cash and securities of each type of fund into a single account.